POSTER: CT-305 Optimizing Post-Chimeric Antigen Receptor (CAR) T-Cell Monitoring: Evidence Across Lisocabtagene Maraleucel (liso-cel) Pivotal Clinical Trials and Real-World Experience
Year: 2025
Type: article
Authors: Manali Kamdar, Mazyar Shadman, Sairah Ahmed, Jeremy S. Abramson, Miguel-Angel Perales, Nausheen Ahmed, Abu-Sayeef Mirza, Iris Isufi, Matthew Frigault, Jennifer L. Crombie, David Miklos, Alberto Vasconcelos, Alessandro Crotta, David Bernasconi, Debasmita Roy, Eric Bleickardt, Marcelo C. Pasquini, Bradley D. Hunter, Matthew Lunning
Institutions: University of Colorado Cancer Center, University of Washington, Fred Hutch Cancer Center, The University of Texas MD Anderson Cancer Center, Harvard University, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, The University of Kansas Cancer Center, Moffitt Cancer Center, Yale University, Dana-Farber Cancer Institute, Stanford University, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), Medical College of Wisconsin, Intermountain Healthcare, LDS Hospital, University of Nebraska Medical Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413791545